Does the degree of hormone receptor positivity influence your decision to perform Oncotype testing?
Since HR low-positive, HER2 neg tumors behave aggressively similar to TNBC, does the degree of HR positivity factor into your decision-making?
Answer from: Medical Oncologist at Academic Institution
In my clinical practice, the degree of hormone receptor (HR) positivity and the clinical characteristics play an important role in ordering the Oncotype testing for HER2-negative tumors. But for 10 to 100%, if the patient is a candidate for chemo or the patient is willing to use this test as part of...
Comments
Medical Oncologist at NYU Winthrop Hospital I do Oncotype Dx in all ER-positive tumors.
Hormo...
I do Oncotype Dx in all ER-positive tumors. Hormo...